127 related articles for article (PubMed ID: 12557224)
1. Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma.
Molenaar JJ; van Sluis P; Boon K; Versteeg R; Caron HN
Genes Chromosomes Cancer; 2003 Mar; 36(3):242-9. PubMed ID: 12557224
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors.
Hibberts NA; Simpson DJ; Bicknell JE; Broome JC; Hoban PR; Clayton RN; Farrell WE
Clin Cancer Res; 1999 Aug; 5(8):2133-9. PubMed ID: 10473097
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
Akervall J; Borg A; Dictor M; Jin C; Jin Y; Tanner M; Isola J; Mertens F; Wennerberg J
Int J Oncol; 2002 Jan; 20(1):45-52. PubMed ID: 11743641
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 is a direct transcriptional target of GATA3 in neuroblastoma tumor cells.
Molenaar JJ; Ebus ME; Koster J; Santo E; Geerts D; Versteeg R; Caron HN
Oncogene; 2010 May; 29(18):2739-45. PubMed ID: 20154722
[TBL] [Abstract][Full Text] [Related]
5. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
6. Copy number defects of G1-cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis.
Molenaar JJ; Koster J; Ebus ME; van Sluis P; Westerhout EM; de Preter K; Gisselsson D; Øra I; Speleman F; Caron HN; Versteeg R
Genes Chromosomes Cancer; 2012 Jan; 51(1):10-9. PubMed ID: 22034077
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 gene (CCND1) mutations in endometrial cancer.
Moreno-Bueno G; Rodríguez-Perales S; Sánchez-Estévez C; Hardisson D; Sarrió D; Prat J; Cigudosa JC; Matias-Guiu X; Palacios J
Oncogene; 2003 Sep; 22(38):6115-8. PubMed ID: 12955092
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells.
Katayama Y; Sakai A; Okikawa Y; Oue N; Asaoku H; Sasaki A; Imanaka F; Tsujimoto T; Takimoto Y; Masuda R; Nakaju N; Otsuki T; Yasui W; Kimura A
Int J Oncol; 2004 Sep; 25(3):579-95. PubMed ID: 15289859
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of cyclin D1 and cyclin E in 1,2-dimethylhydrazine dihydrochloride-induced rat colon carcinogenesis.
Hur K; Kim JR; Yoon BI; Lee JK; Choi JH; Oh GT; Kim DY
J Vet Sci; 2000 Dec; 1(2):121-6. PubMed ID: 14614307
[TBL] [Abstract][Full Text] [Related]
10. A differential PCR system for the determination of CCND1 (cyclin D1) gene amplification in head and neck squamous cell carcinomas.
Schneeberger C; Eder S; Swoboda H; Ullrich R; Zeillinger R
Oral Oncol; 1998 Jul; 34(4):257-60. PubMed ID: 9813719
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma.
Molenaar JJ; Ebus ME; Koster J; van Sluis P; van Noesel CJ; Versteeg R; Caron HN
Cancer Res; 2008 Apr; 68(8):2599-609. PubMed ID: 18413728
[TBL] [Abstract][Full Text] [Related]
12. Frequency and distribution of trisomy 11 in multiple myeloma patients: relation with overexpression of CCND1 and t(11;14).
Guglielmelli T; Giugliano E; Cappia S; Papotti M; Saglio G
Cancer Genet Cytogenet; 2007 Feb; 173(1):51-6. PubMed ID: 17284370
[TBL] [Abstract][Full Text] [Related]
13. Cdx1 inhibits the proliferation of human colon cancer cells by reducing cyclin D1 gene expression.
Lynch J; Keller M; Guo RJ; Yang D; Traber P
Oncogene; 2003 Sep; 22(41):6395-407. PubMed ID: 14508520
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
15. The relative levels of cyclin D1a and D1b alternative transcripts in mantle cell lymphoma may depend more on sample origin than on CCND1 polymorphism.
Carrère N; Belaud-Rotureau MA; Dubus P; Parrens M; de Mascarel A; Merlio JP
Haematologica; 2005 Jun; 90(6):854-6. PubMed ID: 15951302
[TBL] [Abstract][Full Text] [Related]
16. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
Casimiro M; Rodriguez O; Pootrakul L; Aventian M; Lushina N; Cromelin C; Ferzli G; Johnson K; Fricke S; Diba F; Kallakury B; Ohanyerenwa C; Chen M; Ostrowski M; Hung MC; Rabbani SA; Datar R; Cote R; Pestell R; Albanese C
Cancer Res; 2007 May; 67(9):4364-72. PubMed ID: 17483350
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 protein and CCND1 gene expression in colorectal cancer.
Balcerczak E; Pasz-Walczak G; Kumor P; Panczyk M; Kordek R; Wierzbicki R; Mirowski M
Eur J Surg Oncol; 2005 Sep; 31(7):721-6. PubMed ID: 15993030
[TBL] [Abstract][Full Text] [Related]
18. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines.
Hsu LC; Huang X; Seasholtz S; Potter DM; Gollin SM
Oncogene; 2006 Sep; 25(40):5517-26. PubMed ID: 16619035
[TBL] [Abstract][Full Text] [Related]
19. Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif.
Luo Y; Hao Y; Shi TP; Deng WW; Li N
Acta Pharmacol Sin; 2008 May; 29(5):628-33. PubMed ID: 18430372
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
Gautschi O; Ratschiller D; Gugger M; Betticher DC; Heighway J
Lung Cancer; 2007 Jan; 55(1):1-14. PubMed ID: 17070615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
